Percutaneous Epicardial Access Registry

Overview

About this study

This study will look at patient and procedural characteristics of those undergoing EpiAcc, as well as outcomes of procedures using EpiAcc.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

All patients 18 years of age and older undergoing (or who have previously undergone) EpiAcc as part of their standard clinical care for an electrophysiology procedure. Patients will not undergo EpiAcc purely for the research study.

Exclusion Criteria:

Patients undergoing EpiAcc for the purposes of a pericardiocentesis.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Ammar Killu, M.B.B.S.	Closed for enrollment
Jacksonville, Fla. Mayo Clinic principal investigator Christopher McLeod, M.B., Ch.B., Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Ammar Killu, M.B.B.S.

Closed for enrollment

Jacksonville, Fla.

Mayo Clinic principal investigator

Christopher McLeod, M.B., Ch.B., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials